Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange
Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) today announced that the SIX Swiss Stock Exchange has approved the application filed by the company on September 30, 2011, to remove the company's shares from trading on the SIX exchange. This application was filed after the Company's Board of Directors determined that the cost of maintaining the SIX listing was not justified in light of the low trading volume of the Company's shares over the past 12 months. The last day of trading for the company's common stock on the SIX will be January 30, 2012.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.